Heart failure beta-blocker selection — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Bisoprolol
Heart failure with reduced ejection fraction should be treated with an evidence-based beta-blocker when the patient is clinically stable. Bisoprolol is one of the beta-blockers licensed and commonly used for this indication. Non-selective or antiarrhythmic beta-blockers are not appropriate substitutes for routine heart failure optimisation.
Reference: NICE CKS; BNF